drugset / Trial / NCT04687878
The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the effect of intranasal insulin on motor and non-motor symptoms of patients with Parkinson's disease over a 12-week period.
Timeline
- Start
- 2020-01-01
- Primary completion
- 2022-06-20
- Completion
- 2023-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 20 iu | Intranasal |